Barcelona, Spain

Joan Albanell Mestres

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal2 out of 2 
 
Fundacio Institut Mar D'investigacions Mediques (imim)
 patents
silverMedal1 out of 832,880 
Other
 patents
where one patent can have more than one assignee

Years Active: 2017-2021

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Joan Albanell Mestres: Innovator in Cancer Treatment

Introduction

Joan Albanell Mestres is a prominent inventor based in Barcelona, Spain. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 2 patents, his work focuses on identifying mutations in the epidermal growth factor receptor gene, which plays a crucial role in cancer therapy.

Latest Patents

Mestres' latest patents include a method of treating cancer based on identifying mutations in the extracellular domain III of the epidermal growth factor receptor gene. This invention relates to newly identified mutations that lead to amino acid changes, which are highly correlated with resistance to a therapy regimen comprising cetuximab. The invention encompasses peptide sequences and primers to detect these mutations, as well as kits for predicting a subject's response to therapy involving cetuximab. This method is particularly useful for treating metastatic colorectal cancer.

Another significant patent by Mestres involves mutations in the epidermal growth factor receptor gene, which also leads to an amino acid change that correlates with resistance to cetuximab and sensitivity to panitumumab. This invention includes peptide sequences, primers, and probes for detecting such mutations, along with kits for predicting responses to therapy regimens involving cetuximab and/or panitumumab. This invention is applicable to metastatic colorectal cancer and head and neck cancer.

Career Highlights

Throughout his career, Joan Albanell Mestres has worked with notable organizations, including the Fundació Institut Mar d'Investigacions Mèdiques (IMIM). His research has significantly advanced the understanding of cancer treatment and has the potential to improve patient outcomes.

Collaborations

Mestres has collaborated with esteemed colleagues such as Clara Montagut Viladot and Ana Rovira Guerin. These partnerships have fostered a collaborative environment that enhances the innovation process in cancer research.

Conclusion

Joan Albanell Mestres is a key figure in the field of cancer treatment, with his innovative patents paving the way for more effective therapies. His work continues to impact the medical community and offers hope for improved treatment options for cancer patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…